Suzuki Hidemi, Yoshino Ichiro
Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chiba, 260-8670, Japan.
Gen Thorac Cardiovasc Surg. 2016 Apr;64(4):192-6. doi: 10.1007/s11748-016-0630-7. Epub 2016 Feb 19.
Non-small cell lung cancer (NSCLC) harboring a limited number of distant metastases, referred to as the oligometastatic state, has been indicated for surgery for the past several decades. However, whether the strategy of surgical treatment results in a survival benefit for such patients remains controversial. Experientially, however, thoracic surgeons often encounter long-term survivors among surgically resected oligometastatic NSCLC patients. In this article, the current situation of surgical approach and potential future perspective for oligometastatic NSCLC are reviewed.
在过去几十年中，具有少量远处转移（即寡转移状态）的非小细胞肺癌（NSCLC）患者一直被认为适合手术治疗。然而，手术治疗策略是否能使这类患者获得生存获益仍存在争议。不过，根据经验，胸外科医生在接受手术切除的寡转移NSCLC患者中经常会遇到长期存活者。本文将对寡转移NSCLC的手术治疗现状及未来潜在前景进行综述。
